It is a water soluble, iron oxide, macro molecular complex of polynuclear iron (III) hydroxide and partially hydrolysed dextrin (polymaltose)The absorption of ferric iron from Iron (III) Hydroxide Polymaltose Complex is controlled by a feedback mechanism. When Iron (III) Hydroxide Polymaltose Complex comes in contact with the iron binding sides at the mucosal surface, a physiological exchange is assumed to occur. Iron (III) Hydroxide Polymaltose Complex releases the required amount of ferric iron, which is actively transported into the mucosal cell by a carrier protein and from there released for binding to ferritin or transferrin.

CAP.FERUP (THERAPEUTIC USE)Each Capsule Contains:Iron III Hydroxide Polymaltose Complex (equiv to Elemental Iron ) 100mgFolic Acid I.P. 350mcg.Approved Colours used in empty hard gelatin capsules

SYP.FERUP(PROPHYLACTIC USE)Each 5ml Contains:Iron III Hydroxide Polymaltose Complex equiv to Elemental Iron 50mgIn a syrup base.

Treatment of latent iron deficiency and iron deficiency and iron deficiency and anaemia. Prevention of iron and folic acid deficiency before, during and after pregnancy. For prophylatic therapy of iron deficiency to cover the recommended daily dietary allowance during pregnancy and lactation.

Dosage and duration of therapy are dependent upon the extent of iron deficiency. It should be taken during or immediately after meals.

Cap. Ferup in 10 Strips of 10 Capsules each

Syp. Ferup in 150ml Bottle